Search

everythinglearnresearchcommunity

for

Search:↓

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

New mouse models of Pemphigus show severe symptoms and need better treatments.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Compound 7p shows strong potential as an anticancer agent.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

PPCM microspheres can effectively release finasteride over 42 days.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride may reduce prostate cancer risk.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A new compound effectively inhibits human 5α-reductase 1.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.